These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29180209)

  • 81. Diallyl sulfide protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting oxidative stress, inflammation and apoptosis in mice.
    Li M; Wang S; Li X; Jiang L; Wang X; Kou R; Wang Q; Xu L; Zhao N; Xie K
    Food Chem Toxicol; 2018 Oct; 120():500-509. PubMed ID: 30075314
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production.
    He Z; Li X; Chen H; He K; Liu Y; Gong J; Gong J
    Mol Med Rep; 2016 Dec; 14(6):5595-5600. PubMed ID: 27878238
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Secoisolariciresinol and isotaxiresinol inhibit tumor necrosis factor-alpha-dependent hepatic apoptosis in mice.
    Banskota AH; Nguyen NT; Tezuka Y; Le Tran Q; Nobukawa T; Kurashige Y; Sasahara M; Kadota S
    Life Sci; 2004 Apr; 74(22):2781-92. PubMed ID: 15043992
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
    Kang JW; Kim DW; Choi JS; Kim YS; Lee SM
    Food Chem Toxicol; 2013 Jul; 57():132-9. PubMed ID: 23535186
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Polydatin protects against lipopolysaccharide-induced fulminant hepatic failure in D-galactosamine-sensitized mice.
    Wu MJ; Gong X; Jiang R; Zhang L; Li XH; Wan JY
    Int J Immunopathol Pharmacol; 2012; 25(4):923-34. PubMed ID: 23298483
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice.
    Ma L; Gong X; Kuang G; Jiang R; Chen R; Wan J
    Biochem Biophys Res Commun; 2015 May; 461(2):230-6. PubMed ID: 25866179
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Alpha-lipoic acid exerts a liver-protective effect in acute liver injury rats.
    Tanaka Y; Kaibori M; Miki H; Nakatake R; Tokuhara K; Nishizawa M; Okumura T; Kwon AH
    J Surg Res; 2015 Feb; 193(2):675-83. PubMed ID: 25266599
    [TBL] [Abstract][Full Text] [Related]  

  • 88. β-arrestin 2 attenuates lipopolysaccharide-induced liver injury
    Jiang MP; Xu C; Guo YW; Luo QJ; Li L; Liu HL; Jiang J; Chen HX; Wei XQ
    World J Gastroenterol; 2018 Jan; 24(2):216-225. PubMed ID: 29375207
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in mice.
    Liao WQ; Qi YL; Wang L; Dong XM; Xu T; Ding CD; Liu R; Liang WC; Lu LT; Li H; Li WF; Luo GB; Lu XC
    World J Gastroenterol; 2015 Sep; 21(36):10375-84. PubMed ID: 26420964
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats.
    Akashi I; Kagami K; Hirano T; Oka K
    J Pharm Pharmacol; 2009 Apr; 61(4):473-8. PubMed ID: 19298694
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Differential effects of pyrrolidine dithiocarbamate on TNF-alpha-mediated liver injury in two different models of fulminant hepatitis.
    Lu JW; Wang H; Yan-Li J; Zhang C; Ning H; Li XY; Zhang H; Duan ZH; Zhao L; Wei W; Xu DX
    J Hepatol; 2008 Mar; 48(3):442-52. PubMed ID: 18215436
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Suramin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of NF-kappaB activity.
    Goto T; Takeuchi S; Miura K; Ohshima S; Mikami K; Yoneyama K; Sato M; Shibuya T; Watanabe D; Kataoka E; Segawa D; Endo A; Sato W; Yoshino R; Watanabe S
    Cytokine; 2006 Jan; 33(1):28-35. PubMed ID: 16413198
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Potential protective effect of nuclear factor-κB decoy oligodeoxynucleotides on endotoxin-induced liver injury.
    Li JD; Peng Y; Li Q; Xiao JW; Gong JP; Liu ZJ
    Transplant Proc; 2011 Dec; 43(10):3613-7. PubMed ID: 22172814
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Chicoric acid ameliorate inflammation and oxidative stress in Lipopolysaccharide and d-galactosamine induced acute liver injury.
    Li Z; Feng H; Han L; Ding L; Shen B; Tian Y; Zhao L; Jin M; Wang Q; Qin H; Cheng J; Liu G
    J Cell Mol Med; 2020 Mar; 24(5):3022-3033. PubMed ID: 31989756
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced inflammatory liver injury.
    Kuhla A; Eipel C; Abshagen K; Siebert N; Menger MD; Vollmar B
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1069-76. PubMed ID: 19264954
    [TBL] [Abstract][Full Text] [Related]  

  • 96. S-nitrosoglutathione protects lipopolysaccharide-induced acute kidney injury by inhibiting toll-like receptor 4-nuclear factor-κB signal pathway.
    Fan H; Zhao Y; Zhu JH
    J Pharm Pharmacol; 2019 Aug; 71(8):1255-1261. PubMed ID: 31115903
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
    Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
    Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Dexmedetomidine alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury in mice.
    Yang C; He L; Wang C; Huang Y; Wang A; Li X; Ao J
    Int Immunopharmacol; 2019 Jul; 72():367-373. PubMed ID: 31030092
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK/NF-κB pathway.
    Ma JQ; Ding J; Zhang L; Liu CM
    Environ Toxicol Pharmacol; 2014 May; 37(3):975-83. PubMed ID: 24727148
    [TBL] [Abstract][Full Text] [Related]  

  • 100. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
    Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
    Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.